Related references
Note: Only part of the references are listed.MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism
Ming-Qing Du
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)
Clinicopathologic Characteristics and Treatment of Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)
Markus Raderer et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
Emanuele Zucca et al.
BLOOD (2016)
Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients
Akiko Miyagi Maeshima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Histologic transformation in marginal zone lymphomas
A. Conconi et al.
ANNALS OF ONCOLOGY (2015)
Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma
Zilin Nie et al.
Nature Communications (2015)
Incidental detection of malignant lymphoma in subjects in a cancer surveillance programme
Yutaro Kamiyama et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses
Jong W. Yu et al.
PLOS ONE (2015)
Disseminated Gastric MALT Lymphoma with Monoclonal Gammopathy, t(11; 18)(q21;q21), and Subsequent Development of T-Large Granular Lymphocytic Leukemia: A Case Report and Review of the Literature
Riad Akoum et al.
CASE REPORTS IN MEDICINE (2015)
The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling
S. Rosebeck et al.
ONCOGENE (2014)
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
Marzia Varettoni et al.
BLOOD (2013)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Survival of Patients With Marginal Zone Lymphoma Analysis of the Surveillance, Epidemiology, and End Results Database
Adam J. Olszewski et al.
CANCER (2013)
Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study
Emanuele Zucca et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Are you sure this is Waldenstrom macroglobulinemia?
Irene M. Ghobrial
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2012)
Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-κB Activation
Shaun Rosebeck et al.
SCIENCE (2011)
Signaling to NF-κB: Regulation by Ubiquitination
Ingrid E. Wertz et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
t(11;18)(q21;q21)-positive Advanced-stage MALT Lymphoma Associated with Monoclonal Gammopathy : Resistance to Rituximab or Rituximab-containing Chemotherapy
Hitoshi Ohno et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2008)
A dual role for the API2 moiety in API2-MALT1-dependent NF-κB activation:: heterotypic oligomerization and TRAF2 recruitment
P. C. Lucas et al.
ONCOGENE (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery
J Kriangkum et al.
BLOOD (2006)
Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity
HL Zhou et al.
CANCER CELL (2005)
High relapse rate in patients with MALT lymphoma warrants lifelong follow-up
M Raderer et al.
CLINICAL CANCER RESEARCH (2005)
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-κB-dependent proliferative advantage and resistance against FAS-induced cell death in B cells
L Ho et al.
BLOOD (2005)
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) arising in the small intestine with monoclonal cryoglobulinemia
T Saito et al.
PATHOLOGY INTERNATIONAL (2004)
Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma
S Wöhrer et al.
CLINICAL CANCER RESEARCH (2004)
Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites
B Streubel et al.
LEUKEMIA (2004)
CD40 stimulation of human peripheral B lymphocytes:: Distinct response from naive and memory cells
JF Fecteau et al.
JOURNAL OF IMMUNOLOGY (2003)
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
J Greeve et al.
BLOOD (2003)
Detection of two cell populations corresponding to distinct maturation stages in API-2/MLT-positive mucosa-associated lymphoid tissue lymphoma cells proliferating in pleural effusion
Y Kunisaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H-pylori eradication
HX Liu et al.
GASTROENTEROLOGY (2002)
Detection of t(11;18) in MALT-type lymphoma with dual-color fluorescence in situ hybridization and reverse transcriptase-polymerase chain reaction analysis
Y Kobayashi et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2001)
T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphorna that expresses nuclear BCL10
HX Liu et al.
BLOOD (2001)
Somatic hypermutation and B-cell lymphoma
D Dunn-Walters et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
HX Liu et al.
LANCET (2001)
Share Paper
